- Corporate Officers - P
- Pyott David E I
Insider Trading History of Pyott David E I
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pyott David E I since 2015.
This trader's CIK number is 1051578.
At the time of last reporting, Pyott David E I was the Director of Tarsus Pharmaceuticals, Inc.. (stock ticker symbol TARS).
Also see all insider trading activities at Tarsus Pharmaceuticals, Inc..
Note that in the past
PYOTT DAVID E I also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biomarin Pharmaceutical Inc (BMRN) by Pyott David E I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | BMRN | 12,800 | $1,005,145 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Allergan Inc (AGN) by Pyott David E I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | AGN | 0 | $0 | 0 | $0 | 1,379 | $0 |
Yearly summary of insider trading at Avery Dennison Corp (AVY) by Pyott David E I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | AVY | 0 | $0 | 5,027 | $667,183 | 6,441 | $344,019 |
| 2019 | AVY | 0 | $0 | 0 | $0 | 1,977 | $216,738 |
| 2018 | AVY | 0 | $0 | 2,000 | $186,000 | 5,066 | $362,596 |
| 2017 | AVY | 0 | $0 | 2,000 | $188,000 | 4,245 | $291,506 |
| 2016 | AVY | 0 | $0 | 2,000 | $157,220 | 4,620 | $326,378 |
| 2015 | AVY | 0 | $0 | 2,000 | $129,759 | 4,398 | $250,701 |
Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Pyott David E I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ALNY | 0 | $0 | 7,440 | $2,224,560 | 7,440 | $661,788 |
| 2024 | ALNY | 0 | $0 | 32,450 | $7,171,450 | 32,450 | $2,500,175 |
| 2023 | ALNY | 0 | $0 | 0 | $0 | 136 | $0 |
| 2016 | ALNY | 27,900 | $1,032,327 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tarsus Pharmaceuticals, Inc. (TARS) by Pyott David E I
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | TARS | 0 | $0 | 0 | $0 | 1,383 | $0 |
Insider trading activities at 5 companies by Pyott David E I:
1. Biomarin Pharmaceutical Inc (BMRN)
2. Allergan Inc (AGN)
3. Avery Dennison Corp (AVY)
4. Alnylam Pharmaceuticals, Inc. (ALNY)
5. Tarsus Pharmaceuticals, Inc. (TARS)
Table 1. Insider trading of Biomarin Pharmaceutical Inc (BMRN) by Pyott David E I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-08-31 | BMRN | Buy | 12,800 | 78.53 | 1,005,145 |
Table 2. Insider trading of Allergan Inc (AGN) by Pyott David E I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-02-20 | AGN | Option Ex | 1,379 | .00 | 0 |
Table 3. Insider trading of Avery Dennison Corp (AVY) by Pyott David E I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-04-23 | AVY | Option Ex | 1,414 | 107.56 | 152,089 |
| 2020-02-03 | AVY | Option Ex | 5,027 | 38.18 | 191,930 |
| 2020-02-03 | AVY | Sale | 5,027 | 132.72 | 667,183 |
| 2019-05-01 | AVY | Option Ex | 1,977 | 109.63 | 216,738 |
| 2018-11-27 | AVY | Option Ex | 2,000 | 20.64 | 41,280 |
| 2018-11-27 | AVY | Sale | 2,000 | 93.00 | 186,000 |
| 2018-05-01 | AVY | Option Ex | 3,066 | 104.80 | 321,316 |
| 2017-08-28 | AVY | Option Ex | 298 | 52.12 | 15,530 |
| 2017-08-30 | AVY | Option Ex | 1,702 | 52.12 | 88,699 |
| 2017-08-28 | AVY | Sale | 298 | 94.00 | 28,012 |
| 2017-08-30 | AVY | Sale | 1,702 | 94.00 | 159,988 |
| 2017-05-01 | AVY | Option Ex | 2,245 | 83.42 | 187,277 |
| 2016-08-08 | AVY | Sale | 2,000 | 78.61 | 157,220 |
| 2016-08-08 | AVY | Option Ex | 2,000 | 67.80 | 135,590 |
| 2016-04-29 | AVY | Option Ex | 2,620 | 72.82 | 190,788 |
| 2015-11-02 | AVY | Option Ex | 2,000 | 59.47 | 118,930 |
| 2015-11-02 | AVY | Sale | 2,000 | 64.88 | 129,759 |
| 2015-05-01 | AVY | Option Ex | 1,874 | 55.84 | 104,644 |
| 2015-04-26 | AVY | Option Ex | 524 | 51.77 | 27,127 |
Table 4. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Pyott David E I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-24 | ALNY | Sale | 7,440 | 299.00 | 2,224,560 |
| 2025-03-24 | ALNY | Option Ex | 7,440 | 88.95 | 661,788 |
| 2024-06-24 | ALNY | Sale | 32,450 | 221.00 | 7,171,450 |
| 2024-06-24 | ALNY | Option Ex | 32,450 | 77.05 | 2,500,175 |
| 2023-02-23 | ALNY | Option Ex | 136 | .00 | 0 |
| 2016-10-13 | ALNY | Buy | 27,900 | 37.00 | 1,032,327 |
Table 5. Insider trading of Tarsus Pharmaceuticals, Inc. (TARS) by Pyott David E I
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-04-24 | TARS | Option Ex | 1,383 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pyott David E I
(Director of Tarsus Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.